These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11812748)

  • 21. Effect of corticosterone on insulin and glucagon secretion by the isolated perfused rat pancreas.
    Barseghian G; Levine R
    Endocrinology; 1980 Feb; 106(2):547-52. PubMed ID: 6986256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ.
    Johnson DG; Ensinck JW; Koerker D; Palmer J; Goodner CJ
    Endocrinology; 1975 Feb; 96(2):370-4. PubMed ID: 1089535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of PHI on hormonal secretion from perfused rat pancreas.
    Szecówka J; Tendler D; Efendić S
    Am J Physiol; 1983 Oct; 245(4):E313-7. PubMed ID: 6137956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Action of [3,14-L-selenocysteine, 8-D-tryptophan]-somatostatin on insulin and glucagon secretion of the isolated perfused pancrease of the Wistar rat].
    Bierwolf B; Hartrodt B; Neubert R; Jakubke HD; Blech W
    Biomed Biochim Acta; 1986; 45(5):611-8. PubMed ID: 2875714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors.
    Moens K; Flamez D; Van Schravendijk C; Ling Z; Pipeleers D; Schuit F
    Diabetes; 1998 Jan; 47(1):66-72. PubMed ID: 9421376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of enterostatin on insulin, glucagon, and somatostatin secretion in the perfused rat pancreas.
    Silvestre RA; Rodríguez-Gallardo J; Marco J
    Diabetes; 1996 Sep; 45(9):1157-60. PubMed ID: 8772715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The islet-acinar axis of the pancreas: is there a role for glucagon or a glucagon-like peptide?
    von Schönfeld J; Müller MK
    Experientia; 1994 May; 50(5):442-6. PubMed ID: 7515009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual mode of action of glucose pentaacetates on hormonal secretion from the isolated perfused rat pancreas.
    Leclercq-Meyer V; Malaisse WJ
    Am J Physiol; 1998 Oct; 275(4):E610-7. PubMed ID: 9755079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Impact of islet alpha cell loss on insulin secretion].
    Li G; Ye L; Li J; Yang W; Lou J
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1427-31. PubMed ID: 12509929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
    Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
    J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM.
    Thorens B; Waeber G
    Diabetes; 1993 Sep; 42(9):1219-25. PubMed ID: 8349031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.
    Moens K; Heimberg H; Flamez D; Huypens P; Quartier E; Ling Z; Pipeleers D; Gremlich S; Thorens B; Schuit F
    Diabetes; 1996 Feb; 45(2):257-61. PubMed ID: 8549871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ghrelin activates neuronal constitutive nitric oxide synthase in pancreatic islet cells while inhibiting insulin release and stimulating glucagon release.
    Qader SS; Lundquist I; Ekelund M; Håkanson R; Salehi A
    Regul Pept; 2005 May; 128(1):51-6. PubMed ID: 15721487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
    Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Starvation-induced changes of somatostatin, glucagon, and insulin secretion from the isolated perfused rat pancreas.
    Seino S; Sakurai H; Seino Y; Tsuda K; Tanigawa K; Kuzuya H; Goto Y; Imura H
    Diabetes; 1980 Apr; 29(4):323-5. PubMed ID: 6987123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon-like peptide-1 is a physiological incretin in rat.
    Wang Z; Wang RM; Owji AA; Smith DM; Ghatei MA; Bloom SR
    J Clin Invest; 1995 Jan; 95(1):417-21. PubMed ID: 7814643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide YY: intrapancreatic localization and effects on insulin and glucagon secretion in the mouse.
    Böttcher G; Ahrén B; Lundquist I; Sundler F
    Pancreas; 1989; 4(3):282-8. PubMed ID: 2660131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
    Parkes DG; Pittner R; Jodka C; Smith P; Young A
    Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of D-phenylalanine-derivative hypoglycemic agent A-4166 on pancreatic alpha- and beta-cells: comparative study with glibenclamide.
    Hirose H; Maruyama H; Seto Y; Ito K; Fujita T; Dan K; Kanda N; Saruta T; Kato R
    Pharmacology; 1995 Mar; 50(3):175-81. PubMed ID: 7746834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.